These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16145314)

  • 1. Hormonal environment in the induction of breast cancer in castrated rats using dimethylbenzanthracene: influence of the presence or absence of ovarian activity and of treatment with estradiol, tibolone, and raloxifene.
    Callejo J; Cano A; Medina M; Villaronga M; Gonzalez-Bosquet E; Sabria J; Lailla JM
    Menopause; 2005; 12(5):601-8. PubMed ID: 16145314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method.
    Eilertsen AL; Karssemeijer N; Skaane P; Qvigstad E; Sandset PM
    BJOG; 2008 May; 115(6):773-9. PubMed ID: 18355366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of estrogen and estrogenic compounds on cognition in ovariectomized rats.
    Wu J; Zhu Y; Wu J
    Climacteric; 2008 Jun; 11(3):212-20. PubMed ID: 18568786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.
    Lambrinoudaki IV; Christodoulakos GE; Economou EV; Vlachou SA; Panoulis CP; Alexandrou AP; Kouskouni EE; Creatsas GC
    Maturitas; 2008 Jan; 59(1):62-71. PubMed ID: 18164562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tibolone on estrogen biosynthesis in the mammary tissue of postmenopausal monkeys.
    Stute P; Register TC; Blair RM; Cline JM
    Menopause; 2006; 13(2):232-40. PubMed ID: 16645537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
    Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of oestrogenic compounds on monoamine transporters in rat striatum.
    Le Saux M; Di Paolo T
    J Neuroendocrinol; 2006 Jan; 18(1):25-32. PubMed ID: 16451217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of different preparations of hormone therapy on tumor necrosis factor-alpha levels in women with surgical menopause.
    Somunkiran A; Coskun A; Demirci F; Yucel O
    Gynecol Endocrinol; 2008 Feb; 24(2):79-83. PubMed ID: 18210330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of tibolone versus 17beta-estradiol on climacteric symptoms in women with surgical menopause: a randomized, cross-over study.
    Somunkiran A; Erel CT; Demirci F; Senturk ML
    Maturitas; 2007 Jan; 56(1):61-8. PubMed ID: 16831525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis.
    Eilertsen AL; Sandvik L; Mowinckel MC; Andersen TO; Qvigstad E; Sandset PM
    Thromb Res; 2007; 120(3):371-9. PubMed ID: 17156824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs.
    Werner HM; Franke HR; Vermes I
    Climacteric; 2005 Sep; 8(3):294-9. PubMed ID: 16390761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
    Eilertsen AL; Liestøl S; Mowinckel MC; Hemker HC; Sandset PM
    Thromb Haemost; 2007 Jun; 97(6):938-43. PubMed ID: 17549295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hormone replacement therapy on the elemental contents of uterine tissue.
    Ynsa MD; Ager FJ; Millán JC; Gómez-Zubelbia MA; Pinheiro T
    Biol Trace Elem Res; 2004 Oct; 101(1):37-46. PubMed ID: 15516701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol valerate and tibolone: effects upon brain oxidative stress and blood biochemistry during aging in female rats.
    de Aguiar RB; Dickel OE; Cunha RW; Monserrat JM; Barros DM; Martinez PE
    Biogerontology; 2008 Oct; 9(5):285-98. PubMed ID: 18386154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tibolone and conventional HRT on the expression of estrogen and progesterone receptors in the breast.
    Ma L; Hofling M; Masironi B; von Schoultz B; Cline JM; Sahlin L
    Maturitas; 2008 Dec; 61(4):345-9. PubMed ID: 18980817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extract.
    Freudenstein J; Dasenbrock C; Nisslein T
    Cancer Res; 2002 Jun; 62(12):3448-52. PubMed ID: 12067987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of hormone therapies on the urinary excretion of prostacyclin and thromboxane A2.
    Bruce D; Frick A; Rymer J; Robinson J; Ylikorkala O
    Climacteric; 2008; 11(6):447-53. PubMed ID: 18821092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women.
    Christodoulakos GE; Lambrinoudaki IV; Creatsa MG; Economou EV; Siasou Z; Panoulis CP; Kalligerou I; Papadias C
    Climacteric; 2008 Apr; 11(2):155-65. PubMed ID: 18365858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.